Akhu Therapeutics is a biotechnology company based in Irvine, California, focused on developing novel medicines for anxiety and depression in both humans and companion animals.

We are pioneering the development of peptide therapeutics – specifically, innovative treatments designed to be faster, more effective, and safer than traditional antidepressants and anxiolytics. Our research targets key biological pathways involved in mood disorders, offering a potentially transformative approach to patient care.

Akhu Therapeutics is dedicated to addressing the significant unmet needs in the mental health space, leveraging cutting-edge biotechnology to create impactful therapies. We are committed to advancing the science of peptide therapeutics and improving the lives of individuals and animals affected by these conditions.

Founded in 2015, Akhu Therapeutics currently employs a small team of dedicated scientists and researchers, driven by a passion for innovation and a commitment to delivering life-changing medicines.

Peptide Therapeutics | Akhu Therapeutics, Inc.

Service description

Akhu Therapeutics, Inc. Irvine, United States (US)

Price: N/A

Akhu Therapeutics, Inc.
Irvine, United States (US)